{
  "zip": "3001",
  "sector": "Healthcare",
  "fullTimeEmployees": 77,
  "longBusinessSummary": "Oxurion NV, an integrated biopharmaceutical company, develops and commercializes medicines for the treatment of eye diseases and cancer in Belgium and internationally. Its lead product is JETREA used for the treatment of symptomatic vitreomacular adhesion and vitreomacular traction. The company also develops THR-149, a plasma kallikrein inhibitor for the treatment of DME that has completed phase 1 clinical trial; THR-687 an integrin antagonist to treat patients with a diabetic eye disease that has completed phase 1 clinical trial; and TB-403, an anti- placental growth factor for the treatment of medulloblastoma, a pediatric malignant brain tumor. It has collaboration agreements with BioInvent International AB, Bicycle Therapeutics, Parexel, INC Research, and Galapagos. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium.",
  "city": "Leuven",
  "phone": "32 1 675 13 10",
  "country": "Belgium",
  "companyOfficers": [],
  "website": "http://www.oxurion.com",
  "maxAge": 1,
  "address1": "Gaston Geenslaan 1",
  "fax": "32 1 675 13 11",
  "industry": "Biotechnology",
  "previousClose": 3,
  "regularMarketOpen": 3,
  "twoHundredDayAverage": 3.013669,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 3,
  "navPrice": null,
  "averageDailyVolume10Day": 0,
  "totalAssets": null,
  "regularMarketPreviousClose": 3,
  "fiftyDayAverage": 3.1024241,
  "trailingAnnualDividendRate": null,
  "open": 3,
  "averageVolume10days": 0,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 1.046986,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 3,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 12500,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 131091000,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 568,
  "priceToSalesTrailing12Months": null,
  "dayLow": 3,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 12500,
  "fiftyTwoWeekHigh": 3.8,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 2.6,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 3,
  "exchange": "PNK",
  "shortName": "OXURION",
  "longName": "Oxurion NV",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "TBGNF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_850025",
  "uuid": "0d310b12-a63b-3d07-828d-131790cd4131",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 38292000,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": null,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.01988,
  "netIncomeToCommon": null,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.20536,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1593475200,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 29830786,
  "enterpriseValue": 112620000,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 3,
  "logo_url": "https://logo.clearbit.com/oxurion.com"
}